Supplementary Figure S1.tif (2.21 MB)

Supplementary Figure 1 - Small extracellular vesicles from iPSC-derived mesenchymal stem cells ameliorate tendinopathy pain by inhibiting mast cell activation

figure

posted on 2022-03-15, 09:47 authored by Renzhi Gao, Teng Ye, Zhaochen Zhu, Qing Li, Juntao Zhang, Ji Yuan, Bizeng Zhao, Zongping Xie, Yang Wang

Supplementary Information

Abstract

Aims: This study aimed to explore the effect of iMSC-sEVs on acute pain and investigate the underlying mechanisms.

Materials & Methods: The pathology of tendon was accessed by H&E staining, immunohistochemical and immunofluorescent staining. The pain degree was measured by pain-related behaviors. In vitro, we performed -Hexosaminidase release assay, RT-qPCR, Toluidine blue staining, ELISA and RNA-seq.

Results: iMSC-sEVs effectively alleviated acute pain in tendinopathy as well as inhibited activated mast cell infiltration and interactions with nerve fibers in vivo. In vitro, iMSC-sEVs reduced the degranulation of mast cells, the expression of proinflammatory cytokines and genes involved in the HIF-1 signaling pathway.

Conclusions: This study demonstrated iMSC-sEVs relieved tendinopathy-related pain through inhibiting mast cells activation via the HIF-1 signaling pathway.